Implications of socio-cultural contexts for the ethics of clinical trials.

BACKGROUND Health technology assesment (HTA) requires scientifically rigorous experimentation involving patients as subjects. HTA itself is required so that treatment given to patients will be both effective and efficient; this requirement is itself ethical in nature. At the same time it is essential that the methods used in HTA are ethically sound. Most healthcare researchers agree that the most effective and soundest method for assessing treatments is the randomised controlled trial (RCT). However, some researchers believe that the RCT is unethical, either in essence, or for use in some forms of medical research and HTA. Furthermore, many patients seem unable to understand the principles and purposes of the RCT, a factor which is highly detrimental for the validity of informed consent. Informed consent is the key to the ethics of medical research, both in most theories and in all codes of research conduct. Many RCTs therefore risk being unethical in practice, even if ethical in principle. AIM OF REPORT To survey the main objections to the RCT and its alternatives. To assess the philosophical and methodological basis of these objections, and of the methods recommended for addressing them. To identify areas where objections are founded in social or cultural factors normally overlooked in ethical argument about the RCT methodology. To identify alternative arguments or methods which might resolve ethical conflicts in this area. HOW THE RESEARCH WAS CONDUCTED The methods used were adapted from systematic reviews in medicine. Systematic searches of Medline, Psychlit and Sociofile CD-ROM databases; hand-searches of the major journals in general medicine and surgery, medical ethics and philosophy; and searches of books were carried out. The literature survey was restricted to articles published or abstracted in English. A database of the most relevant and useful materials was compiled, and is accessible on the Internet (http://www.liv.ac.uk/sdthomps/page1.html). RESEARCH FINDINGS UNDERSTANDING RCTS AND THEIR ALTERNATIVES: There is some evidence of difficulty in understanding the aims and methods of RCTs, and some disquiet about elements of the RCT methodologies. These objections are well known and much discussed, and concern the use of placebo, the continuation of trials after significant differentials in benefit or harm are apparent, and randomisation. CULTURAL OR RELIGIOUS OBJECTIONS There was an absence of evidence of cultural or religious objections to randomisation, placebo or other kinds of controlled prospective trials. This most likely reflects an absence of research rather than absence of objections. (ABSTRACT TRUNCATED)

[1]  S. Spencer,et al.  The crisis in clinical research. , 1999, JAMA.

[2]  R. Veatch The foundations of bioethics. , 1999, Bioethics.

[3]  N. Andreasen The crisis in clinical research. , 1998, The American journal of psychiatry.

[4]  Thomas A. Kerns Ethical Issues in HIV Vaccine Trials , 1996 .

[5]  J M Anderson,et al.  Empowering patients: issues and strategies. , 1996, Social science & medicine.

[6]  J. Shotter,et al.  Hearing the patient's 'voice': toward a social poetics in diagnostic interviews. , 1996, Social science & medicine.

[7]  What do Patients Want from Medical Research? , 1996, Journal of the Royal Society of Medicine.

[8]  J. Nguyen-Van-Tam,et al.  Vietnamese people in study may have had language difficulties , 1996, BMJ.

[9]  R Smith Commentary: The importance of patients' consent for publication , 1996, BMJ.

[10]  P. Alderson Equipoise as a means of managing uncertainty: personal, communal and proxy. , 1996, Journal of medical ethics.

[11]  R. D'Hooge,et al.  Placebos in clinical practice and research. , 1996, Journal of medical ethics.

[12]  A. Sniderman The governance of clinical trials , 1996, The Lancet.

[13]  A. Buchanan Judging the past. The case of the human radiation experiments. , 1996, The Hastings Center report.

[14]  F. Kee Patients' prerogatives and perceptions of benefit , 1996, BMJ.

[15]  Priscilla Alderson,et al.  Health Care Choices: Making Decisions with Children , 1996 .

[16]  O. Dyer GP struck off for fraud in drug trials , 1996, BMJ.

[17]  A. Maynard,et al.  Introducing a market to the United Kingdom's National Health Service. , 1996, The New England journal of medicine.

[18]  H. Thornton Many subjects in trial were not asked for consent , 1996, BMJ.

[19]  N. Levinsky Social, institutional, and economic barriers to the exercise of patients' rights. , 1996, The New England journal of medicine.

[20]  D. Carnall Doctor struck off for scientific fraud , 1996, BMJ.

[21]  A. Dellinger Subjected to Science: Human Experimentation in America Before the Second World War , 1996 .

[22]  J. Karlawish,et al.  The controversy over emergency research. A review of the issues and suggestions for a resolution. , 1996, American Journal of Respiratory and Critical Care Medicine.

[23]  J. Savulescu,et al.  Altruism by proxy: volunteering children for bone marrow donation , 1996, BMJ.

[24]  F. Davidoff,et al.  Patient-Centered Medicine: A Professional Evolution , 1996 .

[25]  J. Pastorek Patient-physician communication: respect for culture, religion, and autonomy. , 1996, JAMA.

[26]  F. Cutts,et al.  Communities' confidentiality should be maintained and community consent sought , 1996, British medical journal.

[27]  R. Orr Ethical use of placebos in clinical trials. , 1996, The Journal of family practice.

[28]  H. Thornton Patients' preferences and randomised trials. , 1996, Lancet.

[29]  S Senn,et al.  A personal view of some controversies in allocating treatment to patients in clinical trials. , 1995, Statistics in medicine.

[30]  C. Newdick Who Should We Treat?: Law, Patients and Resources in the NHS , 1995 .

[31]  J G Thornton,et al.  Clinical trials and rare diseases: a way out of a conundrum , 1995, BMJ.

[32]  P. Alderson Consent and the Social Context , 1995, Nursing ethics.

[33]  T. Starzl,et al.  Randomised trialomania? The multicentre liver transplant trials of tacrolimus , 1995, The Lancet.

[34]  D G Altman,et al.  Randomised consent designs in cancer clinical trials. , 1995, European journal of cancer.

[35]  B. Charlton Randomized clinical trials: The worst kind of epidemiology? , 1995, Nature Medicine.

[36]  R J Lilford,et al.  Equipoise and the ethics of randomization. , 1995, Journal of the Royal Society of Medicine.

[37]  J. Collier Confusion over use of placebos in clinical trials , 1995, BMJ.

[38]  L. Gostin Informed consent, cultural sensitivity, and respect for persons. , 1995, JAMA.

[39]  L. Rhodes,et al.  Western bioethics on the Navajo reservation. Benefit or harm? , 1995, JAMA.

[40]  Paul J. Garfield Cross district comparison of applications to research ethics committees , 1995, BMJ.

[41]  A. Macfarlane,et al.  Ethics approval for a national postal survey: recent experience , 1995, BMJ.

[42]  A. While Ethics committees: impediments to research or guardians of ethical standards? , 1995, BMJ.

[43]  D. Zion Can Communities Protect Autonomy? Ethical Dilemmas in HIV Preventative Drug Trials , 1995, Cambridge Quarterly of Healthcare Ethics.

[44]  B. Crigger Bioethnography: fieldwork in the lands of medical ethics. , 1995, Medical anthropology quarterly.

[45]  R. Littlewood,et al.  The effectiveness of words: Religion and healing among the Lubavitch of Stamford Hill , 1995, Culture, medicine and psychiatry.

[46]  T. Sensky,et al.  Ethical Debate: Doctors' legal position in treating temporarily incompetent patients , 1995, BMJ.

[47]  S. Berkowitz Ethical Issues in the Case of Surgical Repair of Cleft Palate , 1995 .

[48]  D. C. Ross Using severity rather than randomization for assignment in clinical trials: Monte Carlo tests and practical illustrations of the Robbins-Zhang method. , 1995, Journal of psychiatric research.

[49]  W. Am Ethics and economics of health care. Prognosis, a traditional alternative to futility. , 1995 .

[50]  Mull Jd Innovation and behavior change. Applied anthropology strategies for international health and cross-cultural medicine. , 1995 .

[51]  H. J. Koch The concept of balanced autonomy in therapeutic and nontherapeutic trials. , 1995, Controlled clinical trials.

[52]  M Schumacher,et al.  Randomized and non-randomized patients in clinical trials: experiences with comprehensive cohort studies. , 1995, Statistics in medicine.

[53]  T. Sheldon Consent is not always essential, say Dutch experts , 1995, BMJ.

[54]  M. Ratain,et al.  Perceptions of cancer patients and their physicians involved in phase I trials. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  Gregory B. Brown The Changing Audience for Clinical Trials , 1995 .

[56]  F. Gifford Community-equipoise and the ethics of randomized clinical trials. , 1995, Bioethics.

[57]  R B D'Agostino,et al.  Measuring effectiveness. What to expect without a randomized control group. , 1995, Medical care.

[58]  P. Mcgrath It's ok to say no!: A discussion of ethical issues arising from informed consent to chemotherapy , 1995, Cancer nursing.

[59]  E. Topol,et al.  Are we promoting true informed consent in cardiovascular clinical trials? , 1995, The Journal of cardiovascular nursing.

[60]  M. Ratain,et al.  Pushing the envelope: informed consent in phase I trials. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[61]  R. DeVries Toward a sociologyof bioethics , 1995 .

[62]  S. Verdun-Jones,et al.  Consent to human experimentation in Québec: the application of the Civil Law principle of personal inviolability to protect special populations. , 1995, International journal of law and psychiatry.

[63]  C. Berglund Children in medical research: Australian ethical standards. , 1995, Child: care, health and development.

[64]  D. Berry,et al.  Adaptive assignment versus balanced randomization in clinical trials: a decision analysis. , 1995, Statistics in medicine.

[65]  B. H. Fox,et al.  Who says yes? Identifying selection biases in a psychosocial intervention study of multiple sclerosis. , 1995, Social science & medicine.

[66]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[67]  S. Wear,et al.  A desperate solution: individual autonomy and the double-blind controlled experiment. , 1995, The Journal of medicine and philosophy.

[68]  C. A. Ritrovato,et al.  The Representation of Women in Clinical Drug Trials , 1995 .

[69]  C. Mackay The Evolution of the Institutional Review Board: A Brief Overview of its History , 1995 .

[70]  F. Charatan US religious groups oppose gene patents. , 1995, BMJ.

[71]  J. Mull Innovation and behavior change. Applied anthropology strategies for international health and cross-cultural medicine. , 1995, Infectious disease clinics of North America.

[72]  S. Popper,et al.  Ethics in human experimentation: historical perspectives. , 1995, Military medicine.

[73]  B. Charlton,et al.  Mega-Trials: Methodological Issues and Clinical Implications , 1995, Journal of the Royal College of Physicians of London.

[74]  J. Lilleyman Informed consent: how informed and consent to what? , 1995, Pediatric hematology and oncology.

[75]  D. Freestone Conflict of interests: an introduction. , 1995, Journal of the Royal Society of Medicine.

[76]  Charles Weijer,et al.  The Ethics and Politics of Human Experimentation , 1995 .

[77]  L. Kirmayer,et al.  Symptom Attribution in Cultural Perspective* , 1994, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[78]  R. Ishiwata,et al.  The Physician–Patient Relationship and Medical Ethics in Japan , 1994, Cambridge Quarterly of Healthcare Ethics.

[79]  D. Davis It Ain’t Necessarily So: Clinicians, Bioethics, and Religious Studies , 1994, The Journal of Clinical Ethics.

[80]  D. Dickenson Children's informed consent to treatment: is the law an ass? , 1994, Journal of medical ethics.

[81]  Rosaline Joseph,et al.  Viewpoints and concerns of a clinical trial participant , 1994, Cancer.

[82]  N. L. Roberson Clinical trial participation: Viewpoints from racial/ethnic groups , 1994, Cancer.

[83]  M. Singer,et al.  AIDS and the health crisis of the U.S. urban poor; the perspective of critical medical anthropology. , 1994, Social science & medicine.

[84]  J. Bush The industry perspective on the inclusion of women in clinical trials , 1994, Academic medicine : journal of the Association of American Medical Colleges.

[85]  R. Merkatz,et al.  Historical background of changes in FDA policy on the study and evaluation of drugs in women , 1994, Academic medicine : journal of the Association of American Medical Colleges.

[86]  C. Mccarthy Historical background of clinical trials involving women and minorities , 1994, Academic medicine : journal of the Association of American Medical Colleges.

[87]  S. Choudhry Review of Legal Instruments and Codes on Medical Experimentation with Children , 1994, Cambridge Quarterly of Healthcare Ethics.

[88]  K J Rothman,et al.  The continuing unethical use of placebo controls. , 1994, The New England journal of medicine.

[89]  S L George,et al.  Stopping a clinical trial early: frequentist and Bayesian approaches applied to a CALGB trial in non-small-cell lung cancer. , 1994, Statistics in medicine.

[90]  D J Spiegelhalter,et al.  The what, why and how of Bayesian clinical trials monitoring. , 1994, Statistics in medicine.

[91]  M Baum,et al.  Early stopping rules--clinical perspectives and ethical considerations. , 1994, Statistics in medicine.

[92]  D. Thomasma,et al.  Intercultural Reasoning: The Challenge for International Bioethics , 1994, Cambridge Quarterly of Healthcare Ethics.

[93]  S. Delano,et al.  Protecting mental health research subjects without prohibiting progress. , 1994, Hospital & community psychiatry.

[94]  A. Dula,et al.  African American Suspicion of the Healthcare System Is Justified: What Do We Do about It? , 1994, Cambridge Quarterly of Healthcare Ethics.

[95]  Z. Wu Conflicts between Chinese Traditional Ethics and Bioethics , 1994, Cambridge Quarterly of Healthcare Ethics.

[96]  B. Koenig,et al.  Cultural Aspects of Nondisclosure , 1994, Cambridge Quarterly of Healthcare Ethics.

[97]  R. Schwartz Multiculturalism, Medicine, and the Limits of Autonomy: The Practice of Female Circumcision , 1994, Cambridge Quarterly of Healthcare Ethics.

[98]  R. Z. Schostak Jewish ethical guidelines for resuscitation and artificial nutrition and hydration of the dying elderly. , 1994, Journal of medical ethics.

[99]  Michael Jones Managing patients who refuse blood transfusions: an ethical dilemma. , 1994, BMJ.

[100]  Criteria for standard versus experimental therapy. , 1994, Health affairs.

[101]  C. Perry Conflicts of interest and the physician's duty to inform. , 1994, The American journal of medicine.

[102]  J. Boyle Radical moral disagreement in contemporary health care: a Roman Catholic perspective. , 1994, The Journal of medicine and philosophy.

[103]  A. Scherzer Lessons from The Holocaust for American medicine. , 1994, Journal of the Medical Association of Georgia.

[104]  T. Meade The trouble with ethics committees. , 1994, Journal of the Royal College of Physicians of London.

[105]  S. Sullivan,et al.  Professional Organizations and Healthcare Industry Support: Ethical Conflict? , 1994, Cambridge Quarterly of Healthcare Ethics.

[106]  M. Baum Clinical trials -- a brave new partnership: a response to Mrs. Thornton. , 1994, Journal of medical ethics.

[107]  H. Thornton Clinical trials--a brave new partnership? , 1994, Journal of medical ethics.

[108]  A. Glasier,et al.  Attitudes of women to fetal tissue research. , 1994, Journal of medical ethics.

[109]  B Rogers,et al.  Gender Differences in Research , 1994, AAOHN journal : official journal of the American Association of Occupational Health Nurses.

[110]  R. Winn,et al.  Obstacles to the accrual of patients to clinical trials in the community setting. , 1994, Seminars in oncology.

[111]  P. Leaverton,et al.  Scientific and ethical issues in the use of placebo controls in clinical trials. , 1994, Annual review of public health.

[112]  L. Gerber Psychotherapy with Southeast Asian refugees: implications for treatment of Western patients. , 1994, American journal of psychotherapy.

[113]  S. Y. Tan,et al.  The case of the coercive family. , 1994, Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees.

[114]  P. Allmark An argument against the use of the concept of 'persons' in health care ethics. , 1994, Journal of advanced nursing.

[115]  Dwight Kaufman Cancer therapy and the randomized clinical trial: Good medicine? , 1994, Cancer.

[116]  P. Basch Technology transfer to the developing world: does new technology have any relevance for developing countries? , 1993, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[117]  C R Palmer Ethics and statistical methodology in clinical trials. , 1993, Journal of medical ethics.

[118]  I. Chalmers The Cochrane Collaboration: Preparing, Maintaining, and Disseminating Systematic Reviews of the Effects of Health Care , 1993, Annals of the New York Academy of Sciences.

[119]  A. Sperber,et al.  Methodological issues in conducting a community-based clinical drug trial. , 1993, Family practice research journal.

[120]  R. Gillon Autonomy, respect for autonomy and weakness of will. , 1993, Journal of medical ethics.

[121]  Andrew Herxheimer Clinical trials: two neglected ethical issues. , 1993, Journal of medical ethics.

[122]  R. Souhami,et al.  Fully informed consent can be needlessly cruel. , 1993, BMJ.

[123]  B. Berkman,et al.  Psychosocial effects of cancer economics on patients and their families , 1993, Cancer.

[124]  V. Gamble A legacy of distrust: African Americans and medical research. , 1993, American journal of preventive medicine.

[125]  J. Lantos Informed consent the whole truth for patients? , 1993, Cancer.

[126]  R. Levine Ethics of clinical trials do they help the patient? , 1993, Cancer.

[127]  R. Lenhard A large private university hospital system the johns hopkins oncology center , 1993, Cancer.

[128]  K. Antman Reimbursement issues facing patients, providers, and payers , 1993, Cancer.

[129]  J. Horner Criteria for decision making in local research (ethics) committees. , 1993, Public health.

[130]  H. Freeman,et al.  The impact of clinical trial protocols on patient care systems in a large city hospital access for the socially disadvantaged , 1993, Cancer.

[131]  M J Ratain,et al.  Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents. , 1993, Journal of the National Cancer Institute.

[132]  H. Maier-Lenz Implementing Multicenter, Multinational Clinical Trials , 1993 .

[133]  M. Watling,et al.  Current Experience of Central versus Local Ethics Approval in Multicentre Studies , 1993, Journal of the Royal College of Physicians of London.

[134]  M. Datta You cannot exclude the explanation you have not considered , 1993, The Lancet.

[135]  D A Berry,et al.  A case for Bayesianism in clinical trials. , 1993, Statistics in medicine.

[136]  J Whitehead,et al.  The case for frequentism in clinical trials. , 1993, Statistics in medicine.

[137]  S. Pocock Statistical and ethical issues in monitoring clinical trials. , 1993, Statistics in medicine.

[138]  P. Urbach,et al.  The value of randomization and control in clinical trials. , 1993, Statistics in medicine.

[139]  D. Wermeling,et al.  Current Issues Surrounding Women and Minorities in Drug Trials , 1993, The Annals of pharmacotherapy.

[140]  Carol Nash Interpreting Cultural Difference in Medical Intervention: The Use of Wittgenstein’s “Forms of Life” , 1993, The Journal of Clinical Ethics.

[141]  E. Witztum,et al.  Working with Jewish ultra-orthodox patients: Guidelines for a culturally sensitive therapy , 1993, Culture, medicine and psychiatry.

[142]  C. Fethe Beyond voluntary consent: Hans Jonas on the moral requirements of human experimentation. , 1993, Journal of medical ethics.

[143]  M Gross,et al.  Innovations in surgery. A proposal for phased clinical trials. , 1993, The Journal of bone and joint surgery. British volume.

[144]  M. Sullivan Placebo controls and epistemic control in orthodox medicine. , 1993, The Journal of medicine and philosophy.

[145]  C. Weijer,et al.  In loco parentis. Minimal risk as an ethical threshold for research upon children. , 1993, The Hastings Center report.

[146]  S. Leikin Minors' assent, consent, or dissent to medical research. , 1993, IRB.

[147]  R. Gillon Biomedical ethics in Europe--a need for the POBS? , 1993, Journal of medical ethics.

[148]  S. Reiser,et al.  Protecting research subjects after consent: the case for the "research intermediary. , 1993, IRB.

[149]  J. M. Lee Screening and informed consent. , 1993, The New England journal of medicine.

[150]  S. Millon-Underwood Determinants of participation in state‐of‐the‐art cancer prevention, early detection/screening, and treatment trials among African‐Americans , 1993, Cancer nursing.

[151]  J. S. Homer Criteria for Decision Making in Local Research (Ethics) Committees , 1993 .

[152]  V. Merton The Exclusion of Pregnant, Pregnable, and Once-Pregnable People (a.k.a. Women) from Biomedical Research , 1993, American Journal of Law & Medicine.

[153]  C. Jonas,et al.  Biomedical research on incapacitated people according to French law. , 1993, Medicine and law.

[154]  T. van Willigenburg Communitarian illusions: or why the Dutch proposal for setting priorities in health care must fail. , 1993, Health care analysis : HCA : journal of health philosophy and policy.

[155]  Anne E. Figert,et al.  From Paralysis to Fatigue: A History of Psychosomatic Illness in the Modern Era. , 1993 .

[156]  R. Doll,et al.  Sir Austin Bradford Hill and the progress of medical science. , 1992, BMJ.

[157]  C. Weijer,et al.  Demarcating research and treatment: a systematic approach for the analysis of the ethics of clinical research. , 1992, Clinical research.

[158]  Sheldon H. Harris,et al.  Japanese Biological Warfare Research on Humans: A Case Study of Microbiology and Ethics , 1992, Annals of the New York Academy of Sciences.

[159]  M. Molyneux,et al.  Ethical dilemmas in malaria drug and vaccine trials: a bioethical perspective. , 1992, Journal of medical ethics.

[160]  A. Detsky,et al.  Evidence-based medicine. A new approach to teaching the practice of medicine. , 1992, JAMA.

[161]  N. Christakis Ethics are local: engaging cross-cultural variation in the ethics for clinical research. , 1992, Social science & medicine.

[162]  E. Susman,et al.  Participation in biomedical research: the consent process as viewed by children, adolescents, young adults, and physicians. , 1992, The Journal of pediatrics.

[163]  D J Newell,et al.  Intention-to-treat analysis: implications for quantitative and qualitative research. , 1992, International journal of epidemiology.

[164]  C. Elliott Where ethics comes from and what to do about it. , 1992, The Hastings Center report.

[165]  H. Burchell Vicissitudes in clinical trial research. Subjects, participants, patients. , 1992, Controlled clinical trials.

[166]  L J Mahoney,et al.  Reasons for non‐entry in randomized clinical trials for breast cancer: A single institutional study , 1992, Journal of surgical oncology.

[167]  Y. Thong,et al.  The psychological profile of parents who volunteer their children for clinical research: a controlled study. , 1992, Journal of medical ethics.

[168]  H. Emson Rights, Duties and Responsibilities in Health Care , 1992 .

[169]  J. Cookson Auditing a Research Ethics Committee , 1992, Journal of the Royal College of Physicians of London.

[170]  P. Menzel Equality, autonomy, and efficiency: what health care system should we have? , 1992, The Journal of medicine and philosophy.

[171]  P. Menzel Guest Book Review: Just Doctoring , 1992, American Journal of Law & Medicine.

[172]  P. Armitage Bradford Hill and the randomized controlled trial , 1992 .

[173]  J. Converse,et al.  Interpersonal needs of drug addicts: are they similar across cultures? , 1992, The International journal of the addictions.

[174]  S S Ellenberg,et al.  Randomized consent designs for clinical trials: an update. , 1992, Statistics in Medicine.

[175]  R. Dresser,et al.  Wanted. Single, white male for medical research. , 1992, The Hastings Center report.

[176]  G. Annas,et al.  The changing landscape of human experimentation: Nuremberg, Helsinki, and beyond. , 1992, Health matrix.

[177]  R Simon,et al.  A decade of progress in statistical methodology for clinical trials. , 1991, Statistics in medicine.

[178]  H. Stein,et al.  Medicine and Culture: Varieties of Treatment in the United States, England, West Germany, and France.@@@American Medicine as Culture. , 1991 .

[179]  REVIEW ARTICLE: Correlations and Causes , 1991 .

[180]  A. Delini-Stula,et al.  Placebo-controlled studies in acute schizophrenia — an issue of concern , 1991, European Neuropsychopharmacology.

[181]  R J Levine,et al.  Informed Consent: Some Challenges to the Universal Validity of the Western Model , 1991, Law, medicine & health care : a publication of the American Society of Law & Medicine.

[182]  Just Doctoring: Medical Ethics in the Liberal State , 1991 .

[183]  K. Abt Planning controlled clinical trials on the basis of descriptive data analysis. , 1991, Statistics in medicine.

[184]  Norman Fineman The social construction of noncompliance: Implications for cross-cultural geriatric practice , 1991, Journal of cross-cultural gerontology.

[185]  D. Altman,et al.  Improving Doctors' understanding of statistics , 1991 .

[186]  R. Lilford,et al.  At what level of collective equipoise does a clinical trial become ethical? , 1991, Journal of medical ethics.

[187]  E. Cassell,et al.  The ethics of using scientific data obtained by immoral means. , 1991, New York state journal of medicine.

[188]  S. Epstein Democratic Science? AIDS Activism and the Contested Construction of Knowledge , 1991 .

[189]  H. Llewellyn-Thomas,et al.  Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. , 1991, Social science & medicine.

[190]  R. G. Cornell,et al.  Ethics and statistics in randomized clinical trials. , 1991, Statistical science : a review journal of the Institute of Mathematical Statistics.

[191]  M. H. Pappworth "Human guinea pigs"--a history. , 1990, BMJ.

[192]  P. Allebeck,et al.  A trial that failed, and the reasons why: comparing the Minnesota model with outpatient treatment and non-treatment for alcohol disorders. , 1990, Scandinavian journal of social medicine.

[193]  J. Brown,et al.  Prenatal screening in Jewish law. , 1990, Journal of medical ethics.

[194]  B. Gert,et al.  A critique of principlism. , 1990, The Journal of medicine and philosophy.

[195]  J. Grimshaw Clinical trials: patient perspectives. , 1990, AIDS.

[196]  C. Warren,et al.  Permissions and the social context , 1990, The American sociologist.

[197]  R. Hoffenberg,et al.  Research Involving Patients , 1990, Journal of the Royal College of Physicians of London.

[198]  E. Pellegrino,et al.  The relationship of autonomy and integrity in medical ethics. , 1990, Bulletin of the Pan American Health Organization.

[199]  A. Oakley Who's afraid of the randomized controlled trial? Some dilemmas of the scientific method and "good" research practice. , 1990, Women & health.

[200]  J. O’Neil,et al.  The Cultural and Political Context of Patient Dissatisfaction in Cross‐Cultural Clinical Encounters: A Canadian Inuit Study , 1989 .

[201]  V. Rispler-chaim Islamic medical ethics in the 20th century. , 1989, Journal of medical ethics.

[202]  H. Lesser Obligation and consent. , 1989, Journal of medical ethics.

[203]  T Pullar,et al.  Compliance in clinical trials. , 1989, Annals of the rheumatic diseases.

[204]  W. Staples,et al.  Fieldwork in forbidden terrain: the state, privatization and human subjects regulations , 1989 .

[205]  V. Miké Philosophers assess randomized clinical trials: the need for dialogue. , 1989, Controlled clinical trials.

[206]  S. Rosser Re-visioning Clinical Research: Gender and the Ethics of Experimental Design , 1989, Hypatia.

[207]  J. Wilson‐Barnett Limited autonomy and partnership: professional relationships in health care. , 1989, Journal of medical ethics.

[208]  W. Silverman,et al.  The myth of informed consent: in daily practice and in clinical trials. , 1989, Journal of medical ethics.

[209]  W. Kymlicka Liberalism, Community, and Culture , 1989 .

[210]  P. Benson The social control of human biomedical research: an overview and review of the literature. , 1989, Social science & medicine.

[211]  S C Farrow,et al.  Choosing who shall not be treated in the NHS. , 1989, Social science & medicine.

[212]  A. Feinstein,et al.  Epidemiologic analyses of causation: the unlearned scientific lessons of randomized trials. , 1989, Journal of clinical epidemiology.

[213]  A. Kleinman,et al.  A Methodology for Cross-cultural Ethnomedical Research [and Comments and Reply] , 1988, Current Anthropology.

[214]  William Harper,et al.  Causation in decision, belief change, and statistics , 1988 .

[215]  P. Byrne Medical research and the human subject. Problems of consent and control in the UK experience. , 1988, Annals of the New York Academy of Sciences.

[216]  J Singer,et al.  The consent form as a possible cause of side effects , 1987, Clinical pharmacology and therapeutics.

[217]  B. Freedman Equipoise and the ethics of clinical research. , 1987, The New England journal of medicine.

[218]  THE CONTROLLED CLINICAL TRIAL: CONSENSUS? , 1987, The Lancet.

[219]  A. Brownlea,et al.  Participation: myths, realities and prognosis. , 1987, Social science & medicine.

[220]  C. Mason,et al.  Hippocratic vs. Judeo-Christian medical ethics: principles in conflict. , 1987, The Journal of religious ethics.

[221]  D. Rothman Ethics and human experimentation. Henry Beecher revisited. , 1987, The New England journal of medicine.

[222]  M. Mcguire,et al.  Belief Systems and Illness Experiences: The Case of Non-Medical Healing Groups , 1987 .

[223]  F. Gifford The conflict between randomized clinical trials and the therapeutic obligation. , 1986, The Journal of medicine and philosophy.

[224]  B. Kapp,et al.  A history and theory of informed consent , 1986 .

[225]  S. Fine Do I take the eye out or leave it in? , 1986, Archives of ophthalmology.

[226]  M Zelen,et al.  Case-control studies and Bayesian inference. , 1986, Statistics in medicine.

[227]  R. Bhopal Bhye bhaddi: a food and health concept of Punjabi Asians. , 1986, Social science & medicine.

[228]  H. Heggenhougen,et al.  Cultural components of behavioural epidemiology: implications for primary health care. , 1986, Social science & medicine.

[229]  T. Maretzki,et al.  Biomedicine and naturopathic healing in West Germany a historical and ethnomedical view of a stormy relationship , 1985, Culture, medicine and psychiatry.

[230]  Deborah G. Mayo,et al.  Behavioristic, Evidentialist, and Learning Models of Statistical Testing , 1985, Philosophy of Science.

[231]  D. Berry,et al.  Interim analyses in clinical trials: classical vs. Bayesian approaches. , 1985, Statistics in medicine.

[232]  J. Ashcroft,et al.  Breast Cancer — Patient Choice of Treatment: Preliminary Communication , 1985, Journal of the Royal Society of Medicine.

[233]  A. Caplan Is there a duty to serve as a subject in biomedical research? , 1984, IRB.

[234]  S. Ellenberg Randomization designs in comparative clinical trials. , 1984, The New England journal of medicine.

[235]  G. Anscombe,et al.  Sins of Omission? The Non-Treatment of Controls in Clinical Trials , 1983 .

[236]  K. Brownell,et al.  The double-blind in danger: untoward consequences of informed consent. , 1982, The American journal of psychiatry.

[237]  A. Young The Anthropologies of Illness and Sickness , 1982 .

[238]  Bernard Challenor,et al.  Bad Blood: The Tuskegee Syphilis Experiment , 1982 .

[239]  N. Howard-Jones,et al.  Human experimentation in historical and ethical perspectives. , 1982, Social science & medicine.

[240]  R. Frankenberg Medical anthropology and development: a theoretical perspective. , 1980, Social science & medicine. Medical anthropology.

[241]  G. Giertz Ethics of randomised clinical trials. , 1980, Journal of medical ethics.

[242]  Fowler No Randomized clinical trials in surgery. , 1979 .

[243]  H. Jonas Philosophical Reflections on Experimenting with Human Subjects , 1979 .

[244]  S. Reiser Human Experimentation and the Convergence of Medical Research and Patient Care , 1978 .

[245]  Some determinants of public acceptance of randomized control group experimental designs. , 1976, Sociometry.

[246]  T. Fine,et al.  The Emergence of Probability , 1976 .

[247]  J. Garnham,et al.  Some observations on informed consent in non-therapeutic research. , 1975, Journal of medical ethics.

[248]  L. Debakey Ethically questionable data: publish or reject? , 1974, Clinical research.

[249]  A. L. Cochrane,et al.  Effectiveness and efficiency: random reflections on health services , 1972 .

[250]  R. Lamont-Havers Statistical Methods in Clinical and Preventive Medicine , 1964 .

[251]  Y. Sagara,et al.  Clinical Trial , 1998, Statistical Methods for Biomedical Research.

[252]  W. de B Macnider,et al.  RESEARCH AND THE INDIVIDUAL. , 1945, Science.

[253]  S. Rosenzweig The experimental situation as a psychological problem. , 1933 .